Aemetis, Inc. Faces Revenue Decline Amid Strategic Growth Investments
Aemetis, Inc. (Nasdaq: AMTX) has reported a notable decrease in total revenues for the first quarter of 2025, with figures dropping to $42.9 million from $72.6 million in the same period the previous year. This decline is primarily due to timing shifts in securing new government biodiesel contracts in India. Despite the revenue drop, the […]